Gulf war illness inflammation reduction trial: A phase 2 randomized controlled trial of low-dose prednisone chronotherapy, effects on health-related quality of life

Ronald R. Bach, Rebecca R. Rudquist

Open source

DOI
10.1371/journal.pone.0286817
Published
2023-06-15
Container
PLOS ONE
Publisher
Public Library of Science (PLoS)
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0286817,
  title = {Gulf war illness inflammation reduction trial: A phase 2 randomized controlled trial of low-dose prednisone chronotherapy, effects on health-related quality of life},
  author = {Ronald R. Bach and Rebecca R. Rudquist},
  year = {2023},
  journal = {PLOS ONE},
  doi = {10.1371/journal.pone.0286817},
  url = {https://doi.org/10.1371/journal.pone.0286817}
}

RIS

TY  - JOUR
TI  - Gulf war illness inflammation reduction trial: A phase 2 randomized controlled trial of low-dose prednisone chronotherapy, effects on health-related quality of life
AU  - Ronald R. Bach
AU  - Rebecca R. Rudquist
PY  - 2023
JO  - PLOS ONE
DO  - 10.1371/journal.pone.0286817
UR  - https://doi.org/10.1371/journal.pone.0286817
ER  - 

APA

Bach, R. R., & Rudquist, R. R. (2023). Gulf war illness inflammation reduction trial: A phase 2 randomized controlled trial of low-dose prednisone chronotherapy, effects on health-related quality of life. PLOS ONE. https://doi.org/10.1371/journal.pone.0286817

Source records